Welcome to the New Mexico Chapter of the American College of Cardiology
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!.
For more information and to register, please visit: 
Latest in Cardiology from ACC.org
- Integrated Polygenic Risk Scores Offer Implementable Framework For Predicting CV TraitsIntegrated polygenic risk scores (PRS) offer an implementable framework for genetic risk reporting and are available as a clinically orderable test, according to a validation study using Mass General Brigham Biobank participants and published April 29 in JACC.
- Eagle’s Eye View: Can Cardiorespiratory Fitness Lead to Longer Lifespans?In this week’s View, Dr. Eagle looks at endovascular therapy for post-thrombotic syndrome and how it reduces severity and improves quality of life.
- Could Site Selection Improve Representation in Coronary Stent PMA Studies?Premarket approval (PMA) studies for coronary stents were found to not fully reflect the intended-use population (IUP) due to significant underrepresentation of minority participants and modest underrepresentation of women, according to research on the enrollment implications of site selection published April 29 in JACC.
- Heart Failure Trials Featured at ACC.26ACC.26 featured several late-breaking heart failure clinical trials, including two focused on subgroups of heart failure that until now had limited data to guide therapies.
- NOBLE: Is PCI Equally as Safe as CABG For Patients With Unprotected Left Main CAD?No significant difference was observed in all-cause mortality at 10 years between PCI and CABG in patients with unprotected left main coronary artery disease (CAD) and no additional complex lesions, according to the final results of the NOBLE study published April 4 in The Lancet.